Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Peritoneal Neoplasms 4Stomach Neoplasms 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Appendiceal Neoplasms 2Wilms Tumor 1Sarcoma 1Recurrence 1Pseudomyxoma Peritonei 1Hyperthermia 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Oxaliplatin 53Cisplatin 52Fluorouracil 50Capecitabine 48pembrolizumab 39Leucovorin 31Docetaxel 26Trastuzumab 23Paclitaxel 20Irinotecan 20Ramucirumab 13Bevacizumab 12Cetuximab 9Radiotherapy 8Surgical Procedures, Operative 7S 1 (combination) 7Nivolumab 7Epirubicin 7Carboplatin 6olaparib 5Platinum 5Everolimus 5Sunitinib 4Mitomycin 4trastuzumab deruxtecan 3lenvatinib 3epacadostat 3bemarituzumab 3apatinib 3Saline Solution 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Stomach Neoplasms × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Albert Einstein College of Medicine

Phase 2 Completed
51 enrolled 12 charts
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT01683864 2018-01-30

HIPECStomach

University Hospital Tuebingen

Phase 2/3 Terminated
3 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡